Korsun Neli S, Angelova Svetla G, Trifonova Ivelina T, Voleva Silvia E, Grigorova Iliana G, Tzotcheva Iren S, Mileva Sirma D, Perenovska Penka I
Department of Virology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Pediatric Clinic, University Hospital Alexandrovska, Medical University, Sofia, Bulgaria.
Intervirology. 2021;64(4):194-202. doi: 10.1159/000516821. Epub 2021 Jul 23.
We investigated the prevalence of human metapneumovirus (hMPV) among patients with acute respiratory infections in Bulgaria, and performed genetic characterization of the F gene of these strains.
Nasopharyngeal swabs collected from patients of a range of ages were tested by using real-time PCR for 12 respiratory viruses. The F gene was sequenced, and phylogenetic and amino acid analyses of the F gene/protein were performed.
A total of 1,842 patients were examined during a 3-year period; 1,229 patients (66.7%) were positive for at least one respiratory virus. hMPV was identified in 83 (4.5%) patient samples. Eleven (13%) of hMPV-positive patients were coinfected with another respiratory virus. The hMPV incidence rate in the 2016/2017, 2017/2018, and 2018/2019 winter seasons was 5.4, 5.4, and 3.1%, respectively. hMPV was mainly detected in specimens collected between January and May (89.2% of cases). The incidence of hMPV infection was highest (5.1%) among the youngest age-group (0-4 years), where hMPV was a causative agent in 8.1 and 4.8% of bronchiolitis and pneumonia cases, respectively. Among the patients aged ≥5 years, hMPV was detected in 2.2 and 3.2% of cases of pneumonia and central nervous system infections, respectively. Phylogenetic analysis of the F gene showed that the sequenced hMPV strains belonged to the A2b, B1, and B2 genotypes. Numerous amino acid substitutions were identified compared with the NL00/1 prototype strain.
This study revealed the significant role of hMPV as a causative agent of serious respiratory illnesses in early childhood, and also demonstrated year-to-year changes in hMPV prevalence and genetic diversity in circulating strains.
我们调查了保加利亚急性呼吸道感染患者中人类偏肺病毒(hMPV)的流行情况,并对这些毒株的F基因进行了基因特征分析。
使用实时PCR对从不同年龄段患者采集的鼻咽拭子进行12种呼吸道病毒检测。对F基因进行测序,并对F基因/蛋白进行系统发育和氨基酸分析。
在3年期间共检查了1842例患者;1229例患者(66.7%)至少一种呼吸道病毒呈阳性。在83例(4.5%)患者样本中鉴定出hMPV。11例(13%)hMPV阳性患者合并感染了另一种呼吸道病毒。2016/2017、2017/2018和2018/2019冬季hMPV发病率分别为5.4%、5.4%和3.1%。hMPV主要在1月至5月采集的标本中检测到(89.2%的病例)。hMPV感染发病率在最年轻年龄组(0 - 4岁)中最高(5.1%),其中hMPV分别是8.1%的毛细支气管炎病例和4.8%的肺炎病例的病原体。在≥5岁的患者中,hMPV分别在2.2%的肺炎病例和3.2%的中枢神经系统感染病例中检测到。F基因的系统发育分析表明,测序的hMPV毒株属于A2b、B1和B2基因型。与NL00/1原型毒株相比,鉴定出许多氨基酸替换。
本研究揭示了hMPV作为幼儿严重呼吸道疾病病原体的重要作用,还证明了hMPV流行率和流行毒株基因多样性的逐年变化。